Monthly Archives: November 2018

Mazor Robotics Shareholders Approve Merger Agreement With Medtronic

CAESAREA, Israel, Nov. 19, 2018 /PRNewswire/ -- Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and a leader in the field of robotic guidance systems, today announced that at a Special General Meeting of Shareholders held earlier today, Mazor Robotics shareholders approved the previously announced definitive merger agreement with wholly-owned subsidiaries of Medtronic plc (NYSE: MDT). Approximately

By |2018-11-20T15:11:12+00:00November 20th, 2018|Financial|

Patients with shoulder arthritis have new options to avoid risks of total shoulder replacement

ROSEMONT, Ill., Nov. 16, 2018 /PRNewswire/ -- A new review article published in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) finds arthroscopic (joint replacement or reconstruction) management could be a promising option for young, active patients diagnosed with GHOA. Primary glenohumeral osteoarthritis (GHOA) is a common type of painful and debilitating shoulder osteoarthritis (OA). Shoulder OA leads to upper

By |2018-11-19T20:27:14+00:00November 19th, 2018|Recon|

Michel Orsinger Assumes Role as Chairman of LimaCorporate’s Advisory Board

SAN DANIELE DEL FRIULI, Italy, November 19, 2018 /PRNewswire/ -- LimaCorporate is pleased to announce that Michel Orsinger, Board Member of LimaCorporate's Advisory Board, will assume the role of Chairman of the Board. Michel joined the Advisory Board mid-2017 following a long and successful global career in Orthopaedics. Michel Orsinger held the position of Worldwide Chairman DePuy Synthes Companies at Johnson

By |2018-11-19T17:24:44+00:00November 19th, 2018|Extremities|

BONESUPPORT™ – Positive Results From The CERTiFy Study Comparing Cerament®|Bone Void Filler With Autograft

Lund, Sweden, 08.00 CET, 19 November 2018 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids, today announces positive top-line data from the CERTiFy (CERAMENT® Treatment of Tibia Plateau Fracture defects) study comparing CERAMENT|BVF with autologous iliac bone graft (autograft).BONESUPPORT CEO Emil Billback said:” Successfully completing the ground-breaking CERTiFy study, to demonstrate CERAMENT BVF is non-inferior to autograft

By |2018-11-19T16:20:56+00:00November 19th, 2018|Biologics|

Colfax to Acquire DJO Global for $3.15 Billion in Cash

ANNAPOLIS JUNCTION, MD, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced it has entered into a definitive agreement to acquire DJO Global Inc. (“DJO”) from private equity funds managed by Blackstone for $3.15 billion in cash. DJO is a global leader in orthopedic solutions, providing orthopedic

By |2018-11-19T15:53:47+00:00November 19th, 2018|Financial, Top Stories|

RTI Surgical® Announces HealthPartners’® Positive Coverage Decision for Minimally Invasive Sacroiliac Joint Fusion Surgery

November 19, 2018 ALACHUA, Fla.--(BUSINESS WIRE)--RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, announced HealthPartners, the largest consumer governed nonprofit health care organization in the United States, issued a positive coverage decision for minimally invasive sacroiliac (SI) joint fusion surgery, effective November 1, 2018. This decision expands access to RTI’s SImmetry System for

By |2018-11-19T15:09:31+00:00November 19th, 2018|Spine|

Value-Based Reimbursement Reduces Costs 15.6%, Improves Quality

November 14, 2018 / By Jacqueline LaPointe Value-based reimbursement models are moving the needle on quality and cost, a new analysis from Humana shows. In 2017, medical costs for patients attributed to primary care practices (PCPs) in Humana’s value-based reimbursement models for Medicare Advantage (MA) were 15.6 percent lower compared to Medicare fee-for-service, the insurer reported. Internally, medical

By |2018-11-19T14:53:21+00:00November 19th, 2018|Financial|

Smith & Nephew Presents Excellent Results for JOURNEY™ II Total Knee at the 2018 American Association of Hip and Knee Surgeons

MEMPHIS, Tenn., Nov. 16, 2018 /PRNewswire/ -- Smith & Nephew (LSE: SN,NYSE: SNN), the global medical technology business, presented a number of compelling clinical outcomes around its flagship JOURNEY II BCS knee earlier this month at the American Association of Hip and Knee Surgeons (AAHKS). The announcement follows more than a dozen publications during the past year from

By |2018-11-16T20:52:16+00:00November 16th, 2018|Recon|

AlloSource Granted Patent For Proprietary Laser Cutting Enclosure

CENTENNIAL, Colo., Nov. 16, 2018 /PRNewswire/ -- AlloSource, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue, received U.S. patent 10,105,793, titled Enclosure for laser cutting of human tissue. This patent encompasses AlloSource's method of producing a closed system that allows a laser beam to pass through and etch allograft tissue, while maintaining

By |2018-11-16T20:40:28+00:00November 16th, 2018|Biologics|

Premier Inc. Survey: Nearly 75% of Health Systems Report Interest in Value-Based Contracting

November 15, 2018 CHARLOTTE, N.C. - Although 73 percent of healthcare providers rank value-based contracting with suppliers as a priority for improving return on investments, opportunities lag in the healthcare supply chain, according to a new Premier Inc. survey . Premier®, a leading healthcare improvement company, surveyed health system C-suite leaders, operations managers and heads of materials management

By |2018-11-16T18:20:41+00:00November 16th, 2018|Financial|